IRWD - Ironwood Pharmaceuticals, Inc. - Class A

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.46 0.08 (5.48%) 0.0 (0.0%) 0.03 (1.99%) 0.02 (1.32%) 0.08 (5.48%) --- -0.03 (-1.91%) -0.01 (-0.62%)

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
0.15
Diluted EPS:
0.14
Basic P/E:
10.2667
Diluted P/E:
11.0
RSI(14) 1m:
73.81
VWAP:
1.54
RVol:
0.0069

Events

Period Kind Movement Occurred At
1m Price increase 1m 1.54 +0.02 (+1.15%) Oct 15 08:07
10m Price decrease 10m 1.49 -0.2 (-11.83%) Oct 15 04:12
60m Price increase 60m 1.69 +0.23 (+15.75%) Oct 15 04:11
Day Price increase day 1.69 +0.23 (+15.75%) Oct 15 04:11
60m Price decrease 60m 1.52 -0.09 (-5.53%) Oct 14 19:56

Related News